Volume 17, Number 10—October 2011
Research
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
Table 2
Type of immunosuppression, presence of hematopoietic cell transplant, and outcomes for patients with oseltamivir-resistant pandemic (H1N1) 2009, England and Scotland, April 2009–April 30, 2010*
Type of immunosuppression | No. with oseltamivir-resistant strains | No. with hematopoietic cell transplant | No. admitted to ICU | No. deaths |
---|---|---|---|---|
Leukemia | ||||
Acute lymphocytic | 2 | 1 | ||
Acute myeloid | 3 | 2 | 1 | 1 |
Chronic lymphocytic | 5 | 2 | 2 | 2 |
No precision | 1 | |||
Lymphoma | ||||
Non-Hodgkin | 2 | 1 | 1 | 1 |
Marginal zone | 1 | |||
Mantle cell | 2 | 1 | ||
Multiple myeloma | 1 | 1 | 1 | |
Aplastic anemia | 1 | 1 | ||
Hematologic cancer with no precision | 1 | 1 | ||
TRAPS | 1 | |||
HIV | 1 | 1 | ||
Total | 21 | 8 | 5 | 7
*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome. |
*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome.